Amedeo Smart

Free Medical Literature Service

 

Amedeo

Head and Neck Cancer
  Free Subscription

Articles published in
Br J Cancer
    November 2024
  1. EKSTEDT S, Piersiala K, Kolev A, Farrajota Neves da Silva P, et al
    Phenotypical differences of neutrophils patrolling tumour-draining lymph nodes in head and neck cancer.
    Br J Cancer. 2024 Nov 14. doi: 10.1038/s41416-024-02891.
    >> Share

    October 2024
  2. HOLZMANN KLK, Wolf JL, Stangl S, Lennartz P, et al
    Improved ex vivo fluorescence imaging of human head and neck cancer using the peptide tracer TPP-IRDye800 targeting membrane-bound Hsp70 on tumor cells.
    Br J Cancer. 2024 Oct 15. doi: 10.1038/s41416-024-02872.
    >> Share

  3. ZHOU J, Zhao G, Wang S, Li N, et al
    Systemic therapy in the management of metastatic or locally recurrent adenoid cystic carcinoma of the salivary glands: a systematic review of the last decade.
    Br J Cancer. 2024;131:1021-1031.
    >> Share

  4. CHEN YY, Wang PP, Hu Y, Yuan Y, et al
    Clinical efficacy and immune response of neoadjuvant camrelizumab plus chemotherapy in resectable locally advanced oesophageal squamous cell carcinoma: a phase 2 trial.
    Br J Cancer. 2024;131:1126-1136.
    >> Share

    September 2024
  5. WANG R, Liu S, Chen B, Li Q, et al
    Prognostic significance of PET/CT and its association with immuno-genomic profiling in oesophageal squamous cell carcinoma treated with immunotherapy plus chemoradiotherapy: results from a phase II study.
    Br J Cancer. 2024;131:709-717.
    >> Share

    July 2024
  6. HARA Y, Baba Y, Oda E, Harada K, et al
    Presence of Fusobacterium nucleatum in relation to patient survival and an acidic environment in oesophagogastric junction and gastric cancers.
    Br J Cancer. 2024 Jul 12. doi: 10.1038/s41416-024-02753.
    >> Share

  7. LI T, Sun G, Ye H, Song C, et al
    ESCCPred: a machine learning model for diagnostic prediction of early esophageal squamous cell carcinoma using autoantibody profiles.
    Br J Cancer. 2024 Jul 2. doi: 10.1038/s41416-024-02781.
    >> Share

    May 2024
  8. ZHANG D, Jiang D, Jiang L, Ma J, et al
    HLA-A(+) tertiary lymphoid structures with reactivated tumor infiltrating lymphocytes are associated with a positive immunotherapy response in esophageal squamous cell carcinoma.
    Br J Cancer. 2024 May 18. doi: 10.1038/s41416-024-02712.
    >> Share

  9. OLIVA M, Heirali A, Watson G, Rooney AM, et al
    Prospective manipulation of the gut microbiome with microbial ecosystem therapeutic 4 (MET4) in HPV-related locoregionally-advanced oropharyngeal cancer squamous cell carcinoma (LA-OPSCC) undergoing primary chemoradiation: ROMA2 study.
    Br J Cancer. 2024 May 7. doi: 10.1038/s41416-024-02701.
    >> Share

  10. WANG C, Li Y, Wang L, Han Y, et al
    SPP1 represents a therapeutic target that promotes the progression of oesophageal squamous cell carcinoma by driving M2 macrophage infiltration.
    Br J Cancer. 2024;130:1770-1782.
    >> Share

  11. WANG Z, Tang S, Cai L, Wang Q, et al
    DRP1 inhibition-mediated mitochondrial elongation abolishes cancer stemness, enhances glutaminolysis, and drives ferroptosis in oral squamous cell carcinoma.
    Br J Cancer. 2024;130:1744-1757.
    >> Share

  12. SIJBEN J, Huibertse LJ, Rainey L, Broeders MJM, et al
    Oesophageal cancer awareness and anticipated time to help-seeking: results from a population-based survey.
    Br J Cancer. 2024;130:1795-1802.
    >> Share

    April 2024
  13. MAKOWSKA A, Kontny U, Weiskirchen R
    HeLa cells cross-contaminated nasopharyngeal carcinoma cell lines: Still a common problem.
    Br J Cancer. 2024 Apr 25. doi: 10.1038/s41416-024-02675.
    >> Share

  14. TABATABAEIAN H, Bai Y, Huang R, Chaurasia A, et al
    Navigating therapeutic strategies: HPV classification in head and neck cancer.
    Br J Cancer. 2024 Apr 20. doi: 10.1038/s41416-024-02655.
    >> Share

    March 2024
  15. HIRAI R, Kinugasa H, Yamamoto S, Ako S, et al
    Methylation analysis of DCC gene in saliva samples is an efficient method for non-invasive detection of superficial hypopharyngeal cancer.
    Br J Cancer. 2024 Mar 27. doi: 10.1038/s41416-024-02654.
    >> Share

  16. XU J, Chen D, Wu W, Ji X, et al
    A metabolic map and artificial intelligence-aided identification of nasopharyngeal carcinoma via a single-cell Raman platform.
    Br J Cancer. 2024 Mar 7. doi: 10.1038/s41416-024-02637.
    >> Share

  17. SHANG Q, Jiang Y, Wan Z, Peng J, et al
    The clinical implication and translational research of OSCC differentiation.
    Br J Cancer. 2024;130:660-670.
    >> Share

  18. CHENG Z, Johar A, Nilsson M, Schandl A, et al
    Cancer-related fatigue trajectories up to 5 years after curative treatment for oesophageal cancer.
    Br J Cancer. 2024;130:628-637.
    >> Share

    February 2024
  19. CECCHINI M, Cleary JM, Shyr Y, Chao J, et al
    NCI10066: a Phase 1/2 study of olaparib in combination with ramucirumab in previously treated metastatic gastric and gastroesophageal junction adenocarcinoma.
    Br J Cancer. 2024;130:476-482.
    >> Share

  20. JAVED SR, Lord S, El Badri S, Harman R, et al
    CHARIOT: a phase I study of berzosertib with chemoradiotherapy in oesophageal and other solid cancers using time to event continual reassessment method.
    Br J Cancer. 2024;130:467-475.
    >> Share

    January 2024
  21. LIN W, Chen X, Huang Z, Ding Q, et al
    Identification of novel molecular subtypes to improve the classification framework of nasopharyngeal carcinoma.
    Br J Cancer. 2024 Jan 27. doi: 10.1038/s41416-024-02579.
    >> Share

  22. LI G, Wang H, Zhong J, Bai Y, et al
    Circulating small extracellular vesicle-based miRNA classifier for follicular thyroid carcinoma: a diagnostic study.
    Br J Cancer. 2024 Jan 18. doi: 10.1038/s41416-024-02575.
    >> Share

  23. CHEN Y, Feng Y, Lin Y, Zhou X, et al
    GSTM3 enhances radiosensitivity of nasopharyngeal carcinoma by promoting radiation-induced ferroptosis through USP14/FASN axis and GPX4.
    Br J Cancer. 2024 Jan 16. doi: 10.1038/s41416-024-02574.
    >> Share

  24. STOGBAUER F, Beck S, Ourailidis I, Hess J, et al
    Correction: Tumour budding-based grading as independent prognostic biomarker in HPV-positive and HPV-negative head and neck cancer.
    Br J Cancer. 2024 Jan 8. doi: 10.1038/s41416-023-02521.
    >> Share

  25. HUANG Q, Liu Z, Yu Y, Rong Z, et al
    Prediction of response to neoadjuvant chemo-immunotherapy in patients with esophageal squamous cell carcinoma by a rapid breath test.
    Br J Cancer. 2024 Jan 4. doi: 10.1038/s41416-023-02547.
    >> Share

  26. CLEMENTS HA, Underwood TJ, Petty RD
    Total neoadjuvant therapy in oesophageal and gastro-oesophageal junctional adenocarcinoma.
    Br J Cancer. 2024;130:9-18.
    >> Share

    December 2023
  27. ALMANGUSH A, Makitie AA, Leivo I
    Tumour budding in head and neck cancer: what have we learnt and the next steps towards clinical implementation.
    Br J Cancer. 2023 Dec 14. doi: 10.1038/s41416-023-02531.
    >> Share

  28. SARODE G, Sarode SC
    Comment on "Development and validation of a multivariable model for prediction of malignant transformation and recurrence of oral epithelial dysplasia".
    Br J Cancer. 2023;129:1875-1876.
    >> Share

    November 2023
  29. MAHMOOD H, Shephard A, Hankinson P, Bradburn M, et al
    Development and validation of a multivariable model for prediction of malignant transformation and recurrence of oral epithelial dysplasia.
    Br J Cancer. 2023;129:1599-1607.
    >> Share

  30. MENG X, Zheng A, Wang J, Wu X, et al
    Nimotuzumab plus concurrent chemo-radiotherapy in unresectable locally advanced oesophageal squamous cell carcinoma (ESCC): interim analysis from a Phase 3 clinical trial.
    Br J Cancer. 2023;129:1787-1792.
    >> Share

  31. TOWLE R, Dickman CTD, MacLellan SA, Chen J, et al
    Identification of a serum-based microRNA signature that detects recurrent oral squamous cell carcinoma before it is clinically evident.
    Br J Cancer. 2023;129:1810-1817.
    >> Share

    October 2023
  32. LIU JY, Yu ZL, Fu QY, Zhang LZ, et al
    Immunosuppressive effect of small extracellular vesicle PD-L1 is restricted by co-expression of CD80.
    Br J Cancer. 2023;129:925-934.
    >> Share

    September 2023
  33. PAYNE K, Brooks J, Batis N, Khan N, et al
    Feasibility of mass cytometry proteomic characterisation of circulating tumour cells in head and neck squamous cell carcinoma for deep phenotyping.
    Br J Cancer. 2023 Sep 21. doi: 10.1038/s41416-023-02428.
    >> Share

  34. YI H, Lin Y, Wang X, Mao Y, et al
    Pan-cancer analysis of TRPV2 identifies its potential role as a prognostic and immunologic biomarker in oesophageal cancer.
    Br J Cancer. 2023;129:567-569.
    >> Share

    August 2023
  35. NAKAMURA S, Ohuchida K, Hayashi M, Katayama N, et al
    Tertiary lymphoid structures correlate with enhancement of antitumor immunity in esophageal squamous cell carcinoma.
    Br J Cancer. 2023 Aug 21. doi: 10.1038/s41416-023-02396.
    >> Share

    July 2023
  36. BERNER J, Miebach L, Kordt M, Seebauer C, et al
    Chronic oxidative stress adaptation in head and neck cancer cells generates slow-cyclers with decreased tumour growth in vivo.
    Br J Cancer. 2023 Jul 17. doi: 10.1038/s41416-023-02343.
    >> Share

    June 2023
  37. YU W, Chen Y, Putluri N, Osman A, et al
    Evolution of cisplatin resistance through coordinated metabolic reprogramming of the cellular reductive state.
    Br J Cancer. 2023;128:2013-2024.
    >> Share

  38. DAMANAKIS AI, Gebauer F, Stapper A, Schlosser HA, et al
    Combined regression score predicts outcome after neoadjuvant treatment of oesophageal cancer.
    Br J Cancer. 2023;128:2025-2035.
    >> Share

  39. HAYASHI Y, Makino T, Sato E, Ohshima K, et al
    Density and maturity of peritumoral tertiary lymphoid structures in oesophageal squamous cell carcinoma predicts patient survival and response to immune checkpoint inhibitors.
    Br J Cancer. 2023;128:2175-2185.
    >> Share

    May 2023
  40. APRILE M, Cataldi S, Perfetto C, Federico A, et al
    Targeting metabolism by B-raf inhibitors and diclofenac restrains the viability of BRAF-mutated thyroid carcinomas with Hif-1alpha-mediated glycolytic phenotype.
    Br J Cancer. 2023 May 17. doi: 10.1038/s41416-023-02282.
    >> Share

  41. YAMASAKI M, Miyata H, Yamashita K, Hamakawa T, et al
    Chemoradiotherapy versus triplet chemotherapy as initial therapy for T4b esophageal cancer: survival results from a multicenter randomized Phase 2 trial.
    Br J Cancer. 2023 May 4. doi: 10.1038/s41416-023-02286.
    >> Share

  42. MUHLENBRUCH L, Abou-Kors T, Dubbelaar ML, Bichmann L, et al
    The HLA ligandome of oropharyngeal squamous cell carcinomas reveals shared tumour-exclusive peptides for semi-personalised vaccination.
    Br J Cancer. 2023;128:1777-1787.
    >> Share

  43. NOSE Y, Makino T, Tatsumi M, Tanaka K, et al
    Risk stratification of oesophageal squamous cell carcinoma using change in total lesion glycolysis and number of PET-positive lymph nodes.
    Br J Cancer. 2023;128:1879-1887.
    >> Share

    April 2023
  44. STOGBAUER F, Beck S, Ourailidis I, Hess J, et al
    Tumour budding-based grading as independent prognostic biomarker in HPV-positive and HPV-negative head and neck cancer.
    Br J Cancer. 2023 Apr 12. doi: 10.1038/s41416-023-02240.
    >> Share

  45. KOSUMI K, Baba Y, Yamamura K, Nomoto D, et al
    Intratumour Fusobacterium nucleatum and immune response to oesophageal cancer.
    Br J Cancer. 2023;128:1155-1165.
    >> Share

    March 2023
  46. MAO L, Zhou JJ, Xiao Y, Yang QC, et al
    Immunogenic hypofractionated radiotherapy sensitising head and neck squamous cell carcinoma to anti-PD-L1 therapy in MDSC-dependent manner.
    Br J Cancer. 2023 Mar 28. doi: 10.1038/s41416-023-02230.
    >> Share

  47. ZHAO M, He Y, Zhu N, Song Y, et al
    IL-33/ST2 signaling promotes constitutive and inductive PD-L1 expression and immune escape in oral squamous cell carcinoma.
    Br J Cancer. 2023;128:833-843.
    >> Share

  48. PISULA JI, Datta RR, Valdez LB, Avemarg JR, et al
    Predicting the HER2 status in oesophageal cancer from tissue microarrays using convolutional neural networks.
    Br J Cancer. 2023;128:1369-1376.
    >> Share

  49. WANG Y, Du J, Gao Z, Sun H, et al
    Evolving landscape of PD-L2: bring new light to checkpoint immunotherapy.
    Br J Cancer. 2023;128:1196-1207.
    >> Share

    February 2023
  50. LUDWIG N, Yerneni SS, Harasymczuk M, Szczepanski MJ, et al
    TGFbeta carrying exosomes in plasma: potential biomarkers of cancer progression in patients with head and neck squamous cell carcinoma.
    Br J Cancer. 2023 Feb 21. doi: 10.1038/s41416-023-02184.
    >> Share

  51. CHAVES P, Garrido M, Oliver J, Perez-Ruiz E, et al
    Preclinical models in head and neck squamous cell carcinoma.
    Br J Cancer. 2023 Feb 10. doi: 10.1038/s41416-023-02186.
    >> Share

  52. BASNAYAKE BWMTJ, Leo P, Rao S, Vasani S, et al
    Head and neck cancer patient-derived tumouroid cultures: opportunities and challenges.
    Br J Cancer. 2023 Feb 10. doi: 10.1038/s41416-023-02167.
    >> Share

  53. LAWRIE CH
    Progress in the blood-based diagnosis of oesophageal squamous cell carcinoma (ESCC) using microRNAs: Comment on Komatsu et al. (BJC (2011) 105, 104-111).
    Br J Cancer. 2023;128:446-447.
    >> Share

    December 2022
  54. KO JM, Guo C, Liu C, Ning L, et al
    Clonal relationship and alcohol consumption-associated mutational signature in synchronous hypopharyngeal tumours and oesophageal squamous cell carcinoma.
    Br J Cancer. 2022;127:2166-2174.
    >> Share

  55. CABEZA-SEGURA M, Gambardella V, Gimeno-Valiente F, Carbonell-Asins JA, et al
    Integrative immune transcriptomic classification improves patient selection for precision immunotherapy in advanced gastro-oesophageal adenocarcinoma.
    Br J Cancer. 2022;127:2198-2206.
    >> Share

    November 2022
  56. SUNGUC C, Hawkins MM, Winter DL, Dudley IM, et al
    Risk of subsequent primary oral cancer in a cohort of 69,460 5-year survivors of childhood and adolescent cancer in Europe: the PanCareSurFup study.
    Br J Cancer. 2022 Nov 1. pii: 10.1038/s41416-022-02016.
    >> Share

  57. XUE L, Zhao Z, Wang M, Ma L, et al
    A liquid biopsy signature predicts lymph node metastases in T1 oesophageal squamous cell carcinoma: implications for precision treatment strategy.
    Br J Cancer. 2022;127:2052-2059.
    >> Share

  58. ZAIDI AH, Pratama MY, Omstead AN, Gorbonova A, et al
    A blood-based circulating microbial metagenomic panel for early diagnosis and prognosis of oesophageal adenocarcinoma.
    Br J Cancer. 2022;127:2016-2024.
    >> Share

    October 2022
  59. TRAN TV, Rubino C, Allodji R, Andruccioli M, et al
    Breast cancer risk among thyroid cancer survivors and the role of I-131 treatment.
    Br J Cancer. 2022 Oct 12. pii: 10.1038/s41416-022-01982.
    >> Share

    September 2022
  60. ANDERSON K, Ryan N, Nedungadi D, Lamenza F, et al
    STAT1 is regulated by TRIM24 and promotes immunosuppression in head and neck squamous carcinoma cells, but enhances T cell antitumour immunity in the tumour microenvironment.
    Br J Cancer. 2022;127:624-636.
    >> Share

    August 2022
  61. CAINI S, Del Riccio M, Vettori V, D'Ecclesiis O, et al
    Post-diagnosis smoking cessation and survival of patients with head and neck cancer: a systematic review and meta-analysis.
    Br J Cancer. 2022 Aug 23. pii: 10.1038/s41416-022-01945.
    >> Share

  62. ROSENBERG AJ, Agrawal N, Pearson AT, Gooi Z, et al
    Phase I study of nab-paclitaxel-based induction followed by nab-paclitaxel-based concurrent chemotherapy and re-irradiation in previously treated head and neck squamous cell carcinoma.
    Br J Cancer. 2022 Aug 9. pii: 10.1038/s41416-022-01941.
    >> Share

  63. TANG K, Toyozumi T, Murakami K, Sakata H, et al
    HIF-1alpha stimulates the progression of oesophageal squamous cell carcinoma by activating the Wnt/beta-catenin signalling pathway.
    Br J Cancer. 2022;127:474-487.
    >> Share

  64. LI X, Jiang E, Zhao H, Chen Y, et al
    Glycometabolic reprogramming-mediated proangiogenic phenotype enhancement of cancer-associated fibroblasts in oral squamous cell carcinoma: role of PGC-1alpha/PFKFB3 axis.
    Br J Cancer. 2022;127:449-461.
    >> Share

    July 2022
  65. HUANG R, Li S, Tian C, Zhou P, et al
    Thermal stress involved in TRPV2 promotes tumorigenesis through the pathways of HSP70/27 and PI3K/Akt/mTOR in esophageal squamous cell carcinoma.
    Br J Cancer. 2022 Jul 27. pii: 10.1038/s41416-022-01896.
    >> Share

  66. XIE T, Du K, Liu W, Liu C, et al
    LHX2 facilitates the progression of nasopharyngeal carcinoma via activation of the FGF1/FGFR axis.
    Br J Cancer. 2022 Jul 21. pii: 10.1038/s41416-022-01902.
    >> Share

    June 2022
  67. MASUKUME G, Mmbaga BT, Dzamalala CP, Mlombe YB, et al
    A very-hot food and beverage thermal exposure index and esophageal cancer risk in Malawi and Tanzania: findings from the ESCCAPE case-control studies.
    Br J Cancer. 2022 Jun 29. pii: 10.1038/s41416-022-01890.
    >> Share

  68. RABBANI S, Santoni G, Lagergren J, Xie SH, et al
    Use of anti-androgenic 5alpha-reductase inhibitors and risk of oesophageal and gastric cancer by histological type and anatomical sub-site.
    Br J Cancer. 2022 Jun 17. pii: 10.1038/s41416-022-01872.
    >> Share

  69. MAKINO T, Yamasaki M, Tanaka K, Yamashita K, et al
    Multicenter randomised trial of two versus three courses of preoperative cisplatin and fluorouracil plus docetaxel for locally advanced oesophageal squamous cell carcinoma.
    Br J Cancer. 2022;126:1555-1562.
    >> Share

  70. ALMANGUSH A, Jouhi L, Atula T, Haglund C, et al
    Tumour-infiltrating lymphocytes in oropharyngeal cancer: a validation study according to the criteria of the International Immuno-Oncology Biomarker Working Group.
    Br J Cancer. 2022;126:1589-1594.
    >> Share

    March 2022
  71. BOLGER JC, Donohoe CL, Lowery M, Reynolds JV, et al
    Advances in the curative management of oesophageal cancer.
    Br J Cancer. 2022;126:706-717.
    >> Share

  72. ANDREW TW, Hamnett N, Roy I, Garioch J, et al
    Machine-learning algorithm to predict multidisciplinary team treatment recommendations in the management of basal cell carcinoma.
    Br J Cancer. 2022;126:562-568.
    >> Share

    February 2022
  73. PATEL U, Kannan S, Rane SU, Mittal N, et al
    Prognostic and predictive roles of cancer stem cell markers in head and neck squamous cell carcinoma patients receiving chemoradiotherapy with or without nimotuzumab.
    Br J Cancer. 2022 Feb 9. pii: 10.1038/s41416-022-01730.
    >> Share

  74. FLACH S, Howarth K, Hackinger S, Pipinikas C, et al
    Liquid BIOpsy for MiNimal RESidual DiSease Detection in Head and Neck Squamous Cell Carcinoma (LIONESS)-a personalised circulating tumour DNA analysis in head and neck squamous cell carcinoma.
    Br J Cancer. 2022 Feb 7. pii: 10.1038/s41416-022-01716.
    >> Share

    January 2022
  75. SCHACK LMH, Naderi E, Fachal L, Dorling L, et al
    A genome-wide association study of radiotherapy induced toxicity in head and neck cancer patients identifies a susceptibility locus associated with mucositis.
    Br J Cancer. 2022 Jan 17. pii: 10.1038/s41416-021-01670.
    >> Share

    December 2021
  76. HUTCHISON IL, Ridout F, Cheung SMY, Shah N, et al
    Correction to: Nationwide randomised trial evaluating elective neck dissection for early stage oral cancer (SEND study) with meta-analysis and concurrent real-world cohort.
    Br J Cancer. 2021 Dec 23. pii: 10.1038/s41416-021-01678.
    >> Share

  77. WEI Y, Wu W, Jiang Y, Zhou H, et al
    Nuplazid suppresses esophageal squamous cell carcinoma growth in vitro and in vivo by targeting PAK4.
    Br J Cancer. 2021 Dec 15. pii: 10.1038/s41416-021-01651.
    >> Share

  78. MISHRA V, Singh A, Chen X, Rosenberg AJ, et al
    Application of liquid biopsy as multi-functional biomarkers in head and neck cancer.
    Br J Cancer. 2021 Dec 7. pii: 10.1038/s41416-021-01626.
    >> Share

    November 2021
  79. KOBAYASHI T, Makino T, Yamashita K, Saito T, et al
    APR-246 induces apoptosis and enhances chemo-sensitivity via activation of ROS and TAp73-Noxa signal in oesophageal squamous cell cancer with TP53 missense mutation.
    Br J Cancer. 2021;125:1523-1532.
    >> Share

    October 2021
  80. XIE SH, Santoni G, Lagergren J
    Menopausal hormone therapy and risk of oesophageal adenocarcinoma in a population-based cohort study.
    Br J Cancer. 2021 Oct 20. pii: 10.1038/s41416-021-01575.
    >> Share

  81. THEODORAKI MN, Laban S, Jackson EK, Lotfi R, et al
    Changes in circulating exosome molecular profiles following surgery/(chemo)radiotherapy: early detection of response in head and neck cancer patients.
    Br J Cancer. 2021 Oct 12. pii: 10.1038/s41416-021-01567.
    >> Share

  82. BOUROVA-FLIN E, Derakhshan S, Goudarzi A, Wang T, et al
    The combined detection of Amphiregulin, Cyclin A1 and DDX20/Gemin3 expression predicts aggressive forms of oral squamous cell carcinoma.
    Br J Cancer. 2021;125:1122-1134.
    >> Share

  83. BAXTER MA, Middleton F, Cagney HP, Petty RD, et al
    Resistance to immune checkpoint inhibitors in advanced gastro-oesophageal cancers.
    Br J Cancer. 2021;125:1068-1079.
    >> Share

  84. DE PAULA B, C Smyth E
    Personalising care in oesophageal cancer care with liquid biopsy.
    Br J Cancer. 2021;125:1036-1038.
    >> Share

    September 2021
  85. ZOU Z, Zheng W, Fan H, Deng G, et al
    Aspirin enhances the therapeutic efficacy of cisplatin in oesophageal squamous cell carcinoma by inhibition of putative cancer stem cells.
    Br J Cancer. 2021;125:826-838.
    >> Share

    August 2021
  86. LIANG J, Jin Z, Kuang J, Feng H, et al
    The role of anlotinib-mediated EGFR blockade in a positive feedback loop of CXCL11-EGF-EGFR signalling in anaplastic thyroid cancer angiogenesis.
    Br J Cancer. 2021;125:390-401.
    >> Share

  87. GAO S, Liu Y, Duan X, Liu K, et al
    Porphyromonas gingivalis infection exacerbates oesophageal cancer and promotes resistance to neoadjuvant chemotherapy.
    Br J Cancer. 2021;125:433-444.
    >> Share

  88. SATHASIVAM HP, Kist R, Sloan P, Thomson P, et al
    Predicting the clinical outcome of oral potentially malignant disorders using transcriptomic-based molecular pathology.
    Br J Cancer. 2021;125:413-421.
    >> Share

  89. YUAN Y, Zhao Z, Xue L, Wang G, et al
    Identification of diagnostic markers and lipid dysregulation in oesophageal squamous cell carcinoma through lipidomic analysis and machine learning.
    Br J Cancer. 2021;125:351-357.
    >> Share

  90. DAVERN M, Donlon NE, Power R, Hayes C, et al
    The tumour immune microenvironment in oesophageal cancer.
    Br J Cancer. 2021;125:479-494.
    >> Share

    July 2021
  91. WU P, Xie C, Yang L, Liu Y, et al
    The genomic architectures of tumour-adjacent tissues, plasma and saliva reveal evolutionary underpinnings of relapse in head and neck squamous cell carcinoma.
    Br J Cancer. 2021 Jul 6. pii: 10.1038/s41416-021-01464.
    >> Share

    June 2021
  92. SULKSHANE P, Pawar SN, Waghole R, Pawar SS, et al
    Elevated USP9X drives early-to-late-stage oral tumorigenesis via stabilisation of anti-apoptotic MCL-1 protein and impacts outcome in oral cancers.
    Br J Cancer. 2021 Jun 2. pii: 10.1038/s41416-021-01421.
    >> Share

  93. ZOLGHADR F, Tse N, Loka D, Joun G, et al
    A Wnt-mediated phenotype switch along the epithelial-mesenchymal axis defines resistance and invasion downstream of ionising radiation in oral squamous cell carcinoma.
    Br J Cancer. 2021;124:1921-1933.
    >> Share

  94. SHRIWAS O, Arya R, Mohanty S, Mohapatra P, et al
    RRBP1 rewires cisplatin resistance in oral squamous cell carcinoma by regulating Hippo pathway.
    Br J Cancer. 2021;124:2004-2016.
    >> Share

    May 2021
  95. JENSEN KH, Vogelius I, Moser CE, Andersen E, et al
    Bloodstream infections in head and neck cancer patients after curative-intent radiotherapy: a population-based study from the Danish Head and Neck Cancer Group database.
    Br J Cancer. 2021 May 20. pii: 10.1038/s41416-021-01430.
    >> Share

  96. KNIGHT WRC, Baker CR, Griffin N, Wulaningsih W, et al
    Does a high Mandard score really define a poor response to chemotherapy in oesophageal adenocarcinoma?
    Br J Cancer. 2021;124:1653-1660.
    >> Share

    April 2021
  97. MAHMOOD H, Shaban M, Rajpoot N, Khurram SA, et al
    Artificial Intelligence-based methods in head and neck cancer diagnosis: an overview.
    Br J Cancer. 2021 Apr 19. pii: 10.1038/s41416-021-01386.
    >> Share

    March 2021
  98. OLIVA M, Schneeberger PHH, Rey V, Cho M, et al
    Transitions in oral and gut microbiome of HPV+ oropharyngeal squamous cell carcinoma following definitive chemoradiotherapy (ROMA LA-OPSCC study).
    Br J Cancer. 2021 Mar 10. pii: 10.1038/s41416-020-01253.
    >> Share

  99. LIU Y, Baba Y, Ishimoto T, Tsutsuki H, et al
    Fusobacterium nucleatum confers chemoresistance by modulating autophagy in oesophageal squamous cell carcinoma.
    Br J Cancer. 2021;124:963-974.
    >> Share

    February 2021
  100. NG SP, Bahig H, Jethanandani A, Sturgis EM, et al
    Prognostic significance of pre-treatment neutrophil-to-lymphocyte ratio (NLR) in patients with oropharyngeal cancer treated with radiotherapy.
    Br J Cancer. 2021;124:628-633.
    >> Share

  101. KILLCOYNE S, Fitzgerald RC
    Practical early cancer detection: distinguishing stable from unstable genomes in pre-cancerous tissues.
    Br J Cancer. 2021;124:683-685.
    >> Share

    December 2020
  102. KIM HR, Kang HN, Yun MR, Ju KY, et al
    Mouse-human co-clinical trials demonstrate superior anti-tumour effects of buparlisib (BKM120) and cetuximab combination in squamous cell carcinoma of head and neck.
    Br J Cancer. 2020;123:1720-1729.
    >> Share

  103. PATEL U, Pandey M, Kannan S, Samant TA, et al
    Prognostic and predictive significance of nuclear HIF1alpha expression in locally advanced HNSCC patients treated with chemoradiation with or without nimotuzumab.
    Br J Cancer. 2020;123:1757-1766.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016